General Information of the Compound
Compound ID |
CP0399955
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-(4-quinolin-3-yl-1,3-thiazol-2-yl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C33H29N5O3S2
|
||||||||||||||||||
Molecular Weight |
607.761
|
||||||||||||||||||
Canonical SMILES |
O[C@@H](CNCCc1ccc(NS(=O)(=O)c2ccc(cc2)-c2nc(cs2)-c2cnc3ccccc3c2)cc1)c1cccnc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C33H29N5O3S2/c39-32(26-5-3-16-34-19-26)21-35-17-15-23-7-11-28(12-8-23)38-43(40,41)29-13-9-24(10-14-29)33-37-31(22-42-33)27-18-25-4-1-2-6-30(25)36-20-27/h1-14,16,18-20,22,32,35,38-39H,15,17,21H2/t32-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
DKIKWFPJWNCAOP-YTTGMZPUSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor